STAT3 inhibitors for cancer therapy: Have all roads been explored?
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewAZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells.Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor SurveillanceQuercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Nonsmall- cell Lung-cancer Cell Line, A549.Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosisExpression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulationIn silico model-based inference: an emerging approach for inverse problems in engineering better medicinesRole of STAT3 in lung cancer.Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis.Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling.STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy.Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.Targeting Inflammation in Cancer Prevention and Therapy.Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis.Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.STAT3 inhibition as a therapeutic strategy for leukemia.Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells.STAT3, stem cells, cancer stem cells and p63.Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3)The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
P2860
Q27304386-EB5E5547-7AD8-4764-A0A0-33E32E9AEABDQ34334399-47EA4985-E12C-4685-ACDB-1343B197E551Q35086418-3659DA8C-3B62-4419-83C6-2C5C737921C3Q35232561-44F39844-9888-4776-B9DC-FD9E33B89DD0Q35449469-6B48B7BF-EF3E-4492-9CA2-E50C1CB35535Q35550103-B458CBD3-4A78-41C8-B3C6-0162B464AD2DQ35984945-A2CE48F5-A39E-4942-8D36-DE01EB8734D8Q36086059-B7ADC5BF-91FD-40CA-8F2F-94AADF00E125Q36755491-32438468-5520-4774-A3CA-F4ECFE9C430CQ37268557-D8D3F42A-F239-4E5A-8C85-955E98D794E3Q37670027-273B5F6E-6A94-4951-BDC3-734F04A60F5DQ37721791-9A494AD1-6DBC-4BE3-8F8E-7236D4DBA279Q38265472-E39AFF71-E38E-4C98-8C21-64BE6B03ABE8Q38667977-6DB774ED-E699-4938-8E4A-7944254CFD22Q38794210-48D6C5B6-5B64-4F26-82EA-69F2F3C89B7FQ39027675-6EE8BDB6-D9ED-4C42-A55D-F2CBFF0F6923Q39203633-879624DA-2D48-4247-B7A6-97D91D68ACD0Q42638573-F6771EDE-398E-46EB-810B-7D5328242937Q43239317-FF33496D-926D-4E16-B2FC-776B64CF98E3Q48255352-6383BC2F-648C-4038-9299-9B96BEC95B96Q50128979-7B2BA37C-B00E-46B7-9C42-6C94802480B8Q52339863-3CDE7012-10DF-497D-BB03-25FAD0569FF5Q55637644-7AF7911F-3898-42C6-A27F-BF9785D8FC1FQ58704632-B7F0D827-B969-40E8-8EAF-1F6109BBD350Q58742654-7A32AD3D-84F9-419E-97E3-F4A8AE99357C
P2860
STAT3 inhibitors for cancer therapy: Have all roads been explored?
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@ast
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@en
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@nl
type
label
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@ast
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@en
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@nl
prefLabel
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@ast
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@en
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@nl
P2093
P2860
P356
P1433
P1476
STAT3 inhibitors for cancer therapy: Have all roads been explored?
@en
P2093
Fanny Baran-Marszak
Inès Souissi
Remi Fagard
Valeri Metelev
P2860
P304
P356
10.4161/JKST.22882
P407
P577
2013-01-01T00:00:00Z